Moscow, Russia – March 14th, 2017. Institute for Systems Biology Moscow – a company, providing modeling services for innovative drug design, announced participation in ASCPT 2017 Meeting, which is held on 15-18 March in Washington, DC. ISBM will present several studies and demonstrate an updated version of platform for quantitative systems pharmacology modeling of immune response - Immune Response Template (IRT). Also the ISBM CEO Oleg Demin will take part in the Editorial Board Meeting of the CPT: Pharmacometrics & Systems Pharmacology Journal (Nature Publishing Group).
ISBM is honored for such a great opportunity to share the latest results with colleagues and to show its research integrated in commercial project. On ASCPT2017 Meeting the ISBM team will be focused on the QSP-modeling of immune response. They will present mechanistic approaches for description of the different stages of immune cells lifecycle: maturation, migration, activation and more.
All these theoretical methods were used in the updated platform for “rapid” QSP modeling. With the help of IRT one can create model templates of immune response in a few clicks. This can significantly improve the development of drugs, for example in the field of immuno-oncology.
To learn more about the mechanistic modeling of cell dynamics, to talk with the leading specialists of the Institute for Systems Biology Moscow and to see the possibilities of IRT one can by visiting ISBM stand on March 15-18 from 9 am in Exhibit Hall A / B South, Washington Marriott Wardman Park, Washington, DC, USA.
The poster session materials are shared on the company page http://insysbio.ru/en/publication/materials
| ← | July 2017 | → | ||||
| Mo | Tu | We | Th | Fr | Sa | Su |
|---|---|---|---|---|---|---|
|
1
|
2
| |||||
|
3
|
4
|
5
|
6
|
7
|
8
|
9
|
|
10
|
11
|
12
|
13
|
14
1.
14 Jul 2017 18:49
To predict unpredictable: a platform for modeling of the high-selective oncology drugs was created
Moscow, Russia, July 14, 2017. The scientists from BIND RUS and InSysBio (www.insysbio.ru) published a joint research of the new class of anti-oncology treatment in the Journal of Controlled Release. Unique nanoparticles enriched with medications can deliver its content targeted to the tumor site, and the parameters of their effectiveness are programmed during the forming phase.
|
15
|
16
|
|
17
|
18
|
19
|
20
|
21
|
22
|
23
|
|
24
|
25
1.
25 Jul 2017 13:50
InSysBio LLC Announce Renewal of Agreement with ASTEX Pharmaceuticals Inc.
Moscow, Russia, July 25, 2017 – InSysBio LLC (www.insysbio.ru), one of the pioneers in Quantitative Systems Pharmacology (QSP) modeling and simulation for drug development, announced today a renewal of multi-year Master Service Agreement with ASTEX Pharmaceuticals, Inc.
2.
25 Jul 2017 17:37
InSysBio will present at the American Conference on Pharmacometrics (ACoP8)!
Moscow, Russia, July 26, 2017. - Event announcement. This year the scientific team of InSysBio will make 9 poster presentations in conjunction with leading pharmaceutical companies at ACoP8. Also at the special session "QSP Modular design - Approaches to speed up the QSP model development" Oleg Demin Jr will hold a workshop on modeling with the Immune Response Template (IRT) platform.
|
26
|
27
|
28
|
29
|
30
|
|
31
| ||||||
Thank you for your message! We will get back to you shortly.
